Modern management of prosthetic valve anticoagulation .
Prosthetic heart valves have been effectively used for many years .
Nonetheless , they are associated with risks of thrombosis and thromboembolic events , as well as anticoagulation- anticoagulation-induced bleeding .
Substantial changes in anticoagulation measurement and dosing have occurred during the past several years .
In this review , the rationale for anticoagulation in patients with prosthetic heart valves , the changes in monitoring and dosing , and the comparison of relevant anticoagulation trials are discussed .
On the basis of the existing data , new recommendations regarding lower anticoagulation levels are offered , utilizing a single value goal rather than the traditional therapeutic range .
Perioperative management of anticoagulation is discussed in light of the available literature , and major drug interactions are reviewed .
